These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3535833
1. New advances in animal and human virus vaccines. Rowlands DJ. Adv Biotechnol Processes; 1986; 6():253-85. PubMed ID: 3535833 [No Abstract] [Full Text] [Related]
2. [Problems and concepts of active immunologic prevention of human virus diseases]. Kańtoch M. Przegl Epidemiol; 1985; 39(3-4):354-62. PubMed ID: 3832169 [No Abstract] [Full Text] [Related]
3. The potential of retro-inverso peptides as synthetic vaccines. Van Regenmortel MH, Guichard G, Benkirane N, Briand JP, Muller S, Brown F. Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267 [Abstract] [Full Text] [Related]
4. Live virus vaccines for use in animals. Bostock CJ. Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966 [No Abstract] [Full Text] [Related]
5. Towards antiviral oligopeptide vaccines. Niesters HG, van der Zeijst BA. Microbiol Sci; 1984 Jun; 1(3):55-8. PubMed ID: 6086077 [Abstract] [Full Text] [Related]
6. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. García-Briones MM, Blanco E, Chiva C, Andreu D, Ley V, Sobrino F. Virology; 2004 May 01; 322(2):264-75. PubMed ID: 15110524 [Abstract] [Full Text] [Related]
7. Mimicry of viral epitopes with retro-inverso peptides of increased stability. Benkirane N, Guichard G, Briand JP, Muller S, Brown F, Van Regenmortel MH. Dev Biol Stand; 1996 May 01; 87():283-91. PubMed ID: 8854029 [Abstract] [Full Text] [Related]
8. Recombinant DNA technology for the preparation of subunit vaccines. Bachrach HL. J Am Vet Med Assoc; 1982 Nov 15; 181(10):992-9. PubMed ID: 6129235 [Abstract] [Full Text] [Related]
9. Program for accelerated development of new viral vaccines. Jordan WS. Prog Med Virol; 1988 Nov 15; 35():1-20. PubMed ID: 3051131 [No Abstract] [Full Text] [Related]
10. Subunit vaccines against infection by enveloped viruses. Morein B, Höglund S. Adv Biotechnol Processes; 1990 Nov 15; 14():69-90. PubMed ID: 2222838 [No Abstract] [Full Text] [Related]
11. Mimicking foot-and-mouth disease virus antigens with synthetic peptides. Rowlands DJ. Ann Sclavo Collana Monogr; 1984 Nov 15; 1(2):147-61. PubMed ID: 6100728 [No Abstract] [Full Text] [Related]
15. Strategies for viral vaccines: scientific challenge and regulatory aspects. Schild GC. Parasitology; 1989 Aug 15; 98 Suppl():S13-8. PubMed ID: 2657598 [No Abstract] [Full Text] [Related]
16. Duration of immunity in dogs inoculated with an inactivated feline parvovirus vaccine. Chapek ML, Strauss A, Marshall RF, McClaughry LE. Vet Med Small Anim Clin; 1981 Sep 15; 76(9):1319-24. PubMed ID: 6916555 [No Abstract] [Full Text] [Related]
18. [Prospects for the prevention of viral infections by vaccination (review of the literature)]. Tarasishin LA. Vrach Delo; 1985 Mar 15; (3):119-22. PubMed ID: 2409676 [No Abstract] [Full Text] [Related]
19. Canine parvovirus vaccination. Appel MJ, Carmichael LE, McGregor DD, Pollock RV. Mod Vet Pract; 1980 Dec 15; 61(12):983-5. PubMed ID: 6258042 [No Abstract] [Full Text] [Related]
20. Efficacies of inactivated vaccines against betanodavirus in grouper larvae (Epinephelus coioides) by bath immunization. Kai YH, Chi SC. Vaccine; 2008 Mar 10; 26(11):1450-7. PubMed ID: 18276044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]